Drug Trial Radar · NCT07448610
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Aug 27, 2026
Primary completion
May 3, 2032
Study completion Jun 30, 2032
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose is to address critical evidence in the treatment landscape for Spinal Muscular Atrophy (SMA), specifically focusing on the intrathecal formulation of onasemnogene abeparvovec-brve (ITVISMA®). U.S. Pragmatic Multicenter Study (STREAM).
Conditions
- Spinal Muscular Atrophy
Interventions
Onasemnogene Abeparvovec-brveDrug
administered once via lumbar puncture with systemic corticosteroid prophylaxis per label.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in HFMSE for independently ambulatory participantsTime frame: Baseline, 6, 12, 18 and 24 months
- Change from baseline in RULM for non-ambulatory (including walkers with assistance) participantsTime frame: Baseline, 6, 12, 18 and 24 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Stanford Hospital
Stanford, California · Recruiting
Boston Childrens Hospital
Boston, Massachusetts · Recruiting
Columbia University Medical Center
New York, New York · Recruiting
Ohio State University Medical Center
Columbus, Ohio · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.